Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 154 participants.
Also called NCT02029014
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 154 participants
- Registry
-
NCT02029014
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02029014. Allocation not applicable; no masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2016-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin
- Condition
- Atrial Fibrillation
- Intervention (Device)
- LAA closure system
- Lead sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
Record details
- Record id
cardio:ct-nct02029014- Content hash
9a0ed773680d286ed9e8bb012a67990d8ce7de7468770e3e60f317a4b3c143b6